These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20504488)

  • 1. Behaviour of ?-methylserotonin in rat brain synaptosomes.
    Montine TJ; Sourkes TL
    Neurochem Int; 1989; 15(2):227-31. PubMed ID: 20504488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-methylserotonin, a substitute transmitter for serotonergic neurons.
    Sourkes TL; Montine TJ; Missala K
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):829-32. PubMed ID: 1705718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Methyldopa metabolism in central serotonergic nerve terminals: effects on serotonin levels, synthesis and release.
    Wolf WA; Bobik A
    Eur J Pharmacol; 1989 Apr; 163(1):43-53. PubMed ID: 2472968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms.
    Sanders-Bush E; Bushing JA; Sulser F
    J Pharmacol Exp Ther; 1975 Jan; 192(1):33-41. PubMed ID: 1123726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat.
    Curzon G; Fernando JC; Marsden CA
    Br J Pharmacol; 1978 Aug; 63(4):627-34. PubMed ID: 80243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs.
    Schmidt CJ
    Eur J Pharmacol; 1987 Apr; 136(1):81-8. PubMed ID: 2885204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coincidence of blockade of synaptosomal 5-hydroxytryptamine uptake and decrease in tryptophan hydroxylase activity: effects of fenfluramine.
    Knapp S; Mandell AJ
    J Pharmacol Exp Ther; 1976 Jul; 198(1):123-32. PubMed ID: 933002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and biochemical effects of para-methoxyphenylethylamine.
    Hwang EC; Van Woert MH
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):419-31. PubMed ID: 461968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I; Ross SB
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium changes induced by presynaptic 5-hydroxytryptamine-3 serotonin receptors on isolated terminals from various regions of the rat brain.
    Nayak SV; Rondé P; Spier AD; Lummis SC; Nichols RA
    Neuroscience; 1999; 91(1):107-17. PubMed ID: 10336063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced alterations in the efflux of 5-hydroxytryptamine and of 5-hydroxyindoleacetic acid into superfusates of the rat spinal cord.
    Hammond DL; Tyce GM; Yaksh TL
    Eur J Pharmacol; 1983 Mar; 87(4):441-8. PubMed ID: 6189730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptosomal uptake and levels of serotonin in rat brain areas after p-chloroamphetamine or B-9 lesions.
    Massari VJ; Sanders-Bush E
    Eur J Pharmacol; 1975; 33(2):419-22. PubMed ID: 1102320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic methamphetamine administration on tryptophan hydroxylase activity, [3H]serotonin synaptosomal uptake, and serotonin metabolism in rat brain following systemic tryptophan loading.
    Trulson ME; Trulson VM
    Neuropharmacology; 1982 Jun; 21(6):521-7. PubMed ID: 6180346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional and subcellular localization of Li+ and other cations in the rat brain following long-term lithium administration.
    Lam HR; Christensen S
    J Neurochem; 1992 Oct; 59(4):1372-80. PubMed ID: 1402889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halothane inhibits 5-hydroxytryptamine uptake by synaptosomes from rat brain.
    Martin DC; Adams RJ; Introna RP
    Neuropharmacology; 1990 Jan; 29(1):9-16. PubMed ID: 2304618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menadione-treated synaptosomes as a model for post-ischaemic neuronal damage.
    White EJ; Clark JB
    Biochem J; 1988 Jul; 253(2):425-33. PubMed ID: 3178721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to detect any transport of the irreversible monoamine oxidase inhibitor N-cyclopropyl-4-chloroamphetamine by the carrier of 5-hydroxytryptamine in the brain of the rat in vivo.
    Fagervall I; Ross SB
    Neuropharmacology; 1986 Aug; 25(8):911-3. PubMed ID: 3490629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrasynaptosomal sequestration of [3H]amphetamine and [3H]methylenedioxyamphetamine: characterization suggests the presence of a factor responsible for maintaining sequestration.
    Zaczek R; Culp S; De Souza EB
    J Neurochem; 1990 Jan; 54(1):195-204. PubMed ID: 1967142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the rapid binding of newly accumulated noradrenaline within synaptosomes involves synaptic vesicles.
    White TD
    Brain Res; 1976 May; 108(1):87-96. PubMed ID: 6114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of selective type A or type B monoamine oxidase inhibition on the intrasynaptosomal deamination of (3H)serotonin in rat spinal cord tissue.
    Azzaro AJ; Amedro JB; Brown LM; Smith DJ; Williams GM
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):9-13. PubMed ID: 2467212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.